Nav: Home

Doctors dramatically reduce racial disparities in early-stage lung cancer treatment

February 05, 2019

CHAPEL HILL, NC - Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S. The treatment rates before this three-part intervention were 78 percent for white patients versus 69 percent for black patients. With the intervention in place, treatment rates climbed to 95 percent for white patients and 96.5 percent for black patients.

"These results show promise for all cancer treatment centers," said Samuel Cykert, MD, professor of medicine at the UNC School of Medicine and co-principal investigator of the trial. "One of our participating institutions, Cone Health in Greensboro, NC, is now working towards permanently implementing this intervention into its breast and lung cancer care, and we would like to do further testing with all cancer patient populations."

Cykert and his colleagues previously conducted studies in 2005 and 2009 to find out why race disparities in cancer treatment exist. They found multiple reasons that contribute to the overall reduction in treatment.

"We found there was an implicit bias with many clinicians that made them less willing to take the same risks with patients that were different from them," Cykert said. "A black and a white patient of the same age could require the same surgery, have the same comorbidities, have the same income and insurance, yet white patients were more likely to receive the surgery and get their cancer treated."

Cykert says they additionally found that black cancer patients who did not have a regular source of care might have trust issues or miscommunications with physicians, leading them to drop out of treatment altogether. They also found that denial of their diagnosis played a role in patients seeking treatment.

"With that knowledge, we wanted to build a system that pointed out these lapses in care or communication in real time to help us keep track of patients who would otherwise drop off the grid," said Cykert.

The intervention consisted of three parts: a real-time warning system derived from electronic health records, race-specific feedback to clinical teams on treatment completion rates, and a nurse navigator to engage with patients throughout treatment.

The real-time warning system notified nurse navigators when a patient missed an appointment or treatment milestone. The navigator then reached out to the patient to reengage and bring them back in for treatment. The nurse navigators were encouraged to become familiar with patients and build trust in case of a missed appointment, miscommunication between doctor and patient, or other circumstance that created a potential barrier to care.

Cykert, who is a member of the UNC Lineberger Comprehensive Cancer Center, says he and colleagues came up with the intervention model with help from the Greensboro Health Disparities Collaborative, an academic-community partnership experienced in community-based participatory research. Their goals were to create elements of real-time transparency, race-specific accountability, and enhanced patient-centered communication.

Cykert's team recruited patients aged 18-85 from two multi-institutional prospective trials using identical interventions. Nearly 240 patients were enrolled in an American Cancer Society sponsored study, and around 120 lung cancer patients enrolled in a study sponsored by the National Cancer Institute. Cykert was the principal investigator in the first trial, and co-principal investigator in the second trial along with Geni Eng, DrPH, in UNC Gillings School of Global Public Health, and a national expert in community participatory research.

Along with the UNC Lineberger Comprehensive Care Center and Cone Health Cancer Center, East Carolina University's Leo Jenkins Cancer Center, University of South Carolina School of Medicine, and University of Pittsburgh Medical Center's Hillman Cancer Center participated in the trial.

Researchers are in the process of submitting a grant proposal with the National Cancer Institute to implement this intervention to cover whole cancer center populations rather than study patients alone.
-end-


University of North Carolina Health Care

Related Cancer Treatment Articles:

New possible target for cancer treatment
Scientists at Karolinska Institutet in Sweden report that cancer cells and normal cells use different 'gene switches' in order to regulate the expression of genes that control growth.
Adverse effects, quality of life of treatment vs. no treatment for men with localized prostate cancer
Two studies published by JAMA examine the adverse effects and quality of life as reported by men with localized prostate cancer who chose treatment, observation or active surveillance.
Potential new cancer treatment activates cancer-engulfing cells
Macrophages are a type of white blood cell that can engulf and destroy cancer cells.
IBS breakthrough in the treatment of cancer
The research team, headed by the Center's director Myung Kyungjae, made the announcement in a manuscript published in the American Association for Cancer Research on June 6.
Targeted treatment for liver cancer under way
Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common liver cancer.
Timing the treatment of cancer cells
Timing may not be everything, but it could be important in understanding why an anticancer treatment like radiation produces different results against cancer cells, according to a new study by Sheng-hong Chen and colleagues.
Cancer treatment on a cellular level
The most common treatments for cancer are radiation and chemotherapy.
Cancer Treatment Centers of America hosts second-annual cancer treatments conference
Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference March 5, focused on advances in cancer research, new treatments and patient care.
Cancer treatment: Therapeutic approach gives hope for the treatment of multiple myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy.
New method for better treatment of breast cancer
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling.

Related Cancer Treatment Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...